Recruiting

Observational Study

Sponsor:

Boston Children's Hospital

Code:

NCT04998643

Conditions

Congenital Heart Disease

ICU Acquired Weakness

Catabolic State

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Muscle ultrasound to estimate lean body mass

Study Details

Brief summary:

Background \& Significance. Children with congenital heart disease (CHD) have experienced improved postoperative survival shifting the focus away from minimizing mortality to curtailing morbidities. Critical illness following cardiac surgery induces catabolism which may impact functional status. Catabolism, a state in which protein breakdown exceeds protein synthesis, can lead to lean body mass (LBM) breakdown. LBM loss has been associated with poor clinical outcomes. Muscle ultrasound (mUS) has been utilized to measure LBM changes and the functional status score (FSS) was developed to assess functional status changes in children following hospitalization. The ability to identify LBM loss acutely and its association with FSS changes may lead to earlier interventions to preserve LBM and aid in outcome prediction.

Specific Aims \& Hypotheses. Specific Aim 1 is to identify the percent change in LBM by mUS during the first postoperative week in children following complex cardiac surgery. Specific Aim 2 is to evaluate the relationship between percent change in LBM during the first postoperative week and the FSS at discharge and 6 and 12-month follow-up in children with CHD following complex cardiac surgery. The investigators hypothesize children with CHD following complex cardiac surgery will experience a decline in LBM and that there is a direct relationship between the change in LBM and postoperative FSS follow-up.

Study Design \& Methods. The investigators are conducting a single-center, prospective, observational cohort study. Consecutive children (> 3 months and < 18 years of age) with CHD undergoing biventricular conversion will be enrolled. Patients will undergo a baseline mUS and FSS at the time of the index operation. Interval mUS will be obtained on the third and seventh postoperative day. Discharge mUS and FSS will be obtained and a remote FSS will be requested by the family at 6 and 12-months postoperatively. Demographics, pertinent laboratory, concomitant medications, nutrition and ultrasound variables will be collected.

Outcomes. The primary outcomes will be change in LBM during the first postoperative week and change in FSS at 6 and 12-month follow-up in children following complex cardiac surgery. Change in LBM will be defined as a percent change in cross-sectional area of the quadriceps muscle layer thickness (QMLT). Change in FSS will be significant if the score drops 3 points or more from baseline at postoperative follow-up.

Conditions

Congenital Heart Disease

ICU Acquired Weakness

Catabolic State

Study ID

NCT04998643

Start date

Jul 15, 2022

Status verified date

Jul, 2023

Completion date

Jun 1, 2024

Anticipated

Primary completion date

Dec 30, 2023

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. children > 3 months and < 18 years old,
2. diagnosed with CHD, and
3. undergoing biventricular conversion.

Exclusion Criteria:

1. diagnosis of muscular dystrophy or myopathy,
2. lower extremity injury or infection during the current hospitalization,
3. enrolled in a concurrent nutritional intervention trial, or
4. admitted for palliative care.

Study Design

Enrollment

64 participants

Anticipated

Interventions and Outcome Measures

Interventions

Muscle ultrasound to estimate lean body mass

The investigators will perform serial muscle ultrasounds in the postoperative period to estimate lean body mass.

Primary outcome measure

  • Change in lean body mass [ Time Frame: 7 days postoperatively ]
  • Change in functional status [ Time Frame: 6 and 12 months ]

Central Contacts and Locations

Locations

Boston Children's Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

More Information

Sponsor

Boston Children's Hospital

Last update posted

Jul 19, 2023

Last verified

Jul, 2023

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Boston Children's Hospital on 2023-07-19.